Global GLP-1 Drug Supply, Demand and Key Producers, 2023-2029

September 2023 | 108 pages | ID: G35B02E315CAEN
GlobalInfoResearch

Abstracts

The global GLP-1 Drug market size is expected to reach $ 98000 million by 2029, rising at a market growth of 24.6% CAGR during the forecast period (2023-2029).

This report studies the global GLP-1 Drug production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for GLP-1 Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Drug that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global GLP-1 Drug total production and demand, 2018-2029, (K Units)

Global GLP-1 Drug total production value, 2018-2029, (USD Million)

Global GLP-1 Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1 Drug consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: GLP-1 Drug domestic production, consumption, key domestic manufacturers and share

Global GLP-1 Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global GLP-1 Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global GLP-1 Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global GLP-1 Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Novo Nordisk, Boehringer Ingelheim, GlaxoSmithKline (GSK), East China Pharmaceutical Co., Ltd. and Gan & Lee Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Drug market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global GLP-1 Drug Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global GLP-1 Drug Market, Segmentation by Type

• Short-acting GLP-1 Drug
• Long-acting GLP-1 Drug

Global GLP-1 Drug Market, Segmentation by Application

• Obesity
• Type 2 Diabetes (T2DM)
• Cardiovascular and Cerebrovascular Diseases (CVD)
• Non-alcoholic Steatohepatitis (NASH)
• Alzheimer's Disease (AD)

Companies Profiled:

• Eli Lilly
• AstraZeneca
• Sanofi
• Pfizer Inc
• Novo Nordisk
• Boehringer Ingelheim
• GlaxoSmithKline (GSK)
• East China Pharmaceutical Co., Ltd.
• Gan & Lee Pharmaceuticals
• Tonghua Dongbao
• Shanghai Renhui Biopharmaceutical Co., Ltd.
• Jiangsu Hansoh Pharmaceutical Group Co., Ltd.

Key Questions Answered

1. How big is the global GLP-1 Drug market?

2. What is the demand of the global GLP-1 Drug market?

3. What is the year over year growth of the global GLP-1 Drug market?

4. What is the production and production value of the global GLP-1 Drug market?

5. Who are the key producers in the global GLP-1 Drug market?

Contents

1 SUPPLY SUMMARY

1.1 GLP-1 Drug Introduction
1.2 World GLP-1 Drug Supply & Forecast
  1.2.1 World GLP-1 Drug Production Value (2018 & 2022 & 2029)
  1.2.2 World GLP-1 Drug Production (2018-2029)
  1.2.3 World GLP-1 Drug Pricing Trends (2018-2029)
1.3 World GLP-1 Drug Production by Region (Based on Production Site)
  1.3.1 World GLP-1 Drug Production Value by Region (2018-2029)
  1.3.2 World GLP-1 Drug Production by Region (2018-2029)
  1.3.3 World GLP-1 Drug Average Price by Region (2018-2029)
  1.3.4 North America GLP-1 Drug Production (2018-2029)
  1.3.5 Europe GLP-1 Drug Production (2018-2029)
  1.3.6 China GLP-1 Drug Production (2018-2029)
  1.3.7 Japan GLP-1 Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 GLP-1 Drug Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 GLP-1 Drug Major Market Trends

2 DEMAND SUMMARY

2.1 World GLP-1 Drug Demand (2018-2029)
2.2 World GLP-1 Drug Consumption by Region
  2.2.1 World GLP-1 Drug Consumption by Region (2018-2023)
  2.2.2 World GLP-1 Drug Consumption Forecast by Region (2024-2029)
2.3 United States GLP-1 Drug Consumption (2018-2029)
2.4 China GLP-1 Drug Consumption (2018-2029)
2.5 Europe GLP-1 Drug Consumption (2018-2029)
2.6 Japan GLP-1 Drug Consumption (2018-2029)
2.7 South Korea GLP-1 Drug Consumption (2018-2029)
2.8 ASEAN GLP-1 Drug Consumption (2018-2029)
2.9 India GLP-1 Drug Consumption (2018-2029)

3 WORLD GLP-1 DRUG MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World GLP-1 Drug Production Value by Manufacturer (2018-2023)
3.2 World GLP-1 Drug Production by Manufacturer (2018-2023)
3.3 World GLP-1 Drug Average Price by Manufacturer (2018-2023)
3.4 GLP-1 Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global GLP-1 Drug Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for GLP-1 Drug in 2022
  3.5.3 Global Concentration Ratios (CR8) for GLP-1 Drug in 2022
3.6 GLP-1 Drug Market: Overall Company Footprint Analysis
  3.6.1 GLP-1 Drug Market: Region Footprint
  3.6.2 GLP-1 Drug Market: Company Product Type Footprint
  3.6.3 GLP-1 Drug Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: GLP-1 Drug Production Value Comparison
  4.1.1 United States VS China: GLP-1 Drug Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: GLP-1 Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: GLP-1 Drug Production Comparison
  4.2.1 United States VS China: GLP-1 Drug Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: GLP-1 Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: GLP-1 Drug Consumption Comparison
  4.3.1 United States VS China: GLP-1 Drug Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: GLP-1 Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based GLP-1 Drug Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based GLP-1 Drug Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers GLP-1 Drug Production Value (2018-2023)
  4.4.3 United States Based Manufacturers GLP-1 Drug Production (2018-2023)
4.5 China Based GLP-1 Drug Manufacturers and Market Share
  4.5.1 China Based GLP-1 Drug Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers GLP-1 Drug Production Value (2018-2023)
  4.5.3 China Based Manufacturers GLP-1 Drug Production (2018-2023)
4.6 Rest of World Based GLP-1 Drug Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based GLP-1 Drug Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers GLP-1 Drug Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers GLP-1 Drug Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World GLP-1 Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Short-acting GLP-1 Drug
  5.2.2 Long-acting GLP-1 Drug
5.3 Market Segment by Type
  5.3.1 World GLP-1 Drug Production by Type (2018-2029)
  5.3.2 World GLP-1 Drug Production Value by Type (2018-2029)
  5.3.3 World GLP-1 Drug Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World GLP-1 Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Obesity
  6.2.2 Type 2 Diabetes (T2DM)
  6.2.3 Cardiovascular and Cerebrovascular Diseases (CVD)
  6.2.4 Non-alcoholic Steatohepatitis (NASH)
  6.2.5 Alzheimer's Disease (AD)
6.3 Market Segment by Application
  6.3.1 World GLP-1 Drug Production by Application (2018-2029)
  6.3.2 World GLP-1 Drug Production Value by Application (2018-2029)
  6.3.3 World GLP-1 Drug Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Details
  7.1.2 Eli Lilly Major Business
  7.1.3 Eli Lilly GLP-1 Drug Product and Services
  7.1.4 Eli Lilly GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Eli Lilly Recent Developments/Updates
  7.1.6 Eli Lilly Competitive Strengths & Weaknesses
7.2 AstraZeneca
  7.2.1 AstraZeneca Details
  7.2.2 AstraZeneca Major Business
  7.2.3 AstraZeneca GLP-1 Drug Product and Services
  7.2.4 AstraZeneca GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 AstraZeneca Recent Developments/Updates
  7.2.6 AstraZeneca Competitive Strengths & Weaknesses
7.3 Sanofi
  7.3.1 Sanofi Details
  7.3.2 Sanofi Major Business
  7.3.3 Sanofi GLP-1 Drug Product and Services
  7.3.4 Sanofi GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Sanofi Recent Developments/Updates
  7.3.6 Sanofi Competitive Strengths & Weaknesses
7.4 Pfizer Inc
  7.4.1 Pfizer Inc Details
  7.4.2 Pfizer Inc Major Business
  7.4.3 Pfizer Inc GLP-1 Drug Product and Services
  7.4.4 Pfizer Inc GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Pfizer Inc Recent Developments/Updates
  7.4.6 Pfizer Inc Competitive Strengths & Weaknesses
7.5 Novo Nordisk
  7.5.1 Novo Nordisk Details
  7.5.2 Novo Nordisk Major Business
  7.5.3 Novo Nordisk GLP-1 Drug Product and Services
  7.5.4 Novo Nordisk GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Novo Nordisk Recent Developments/Updates
  7.5.6 Novo Nordisk Competitive Strengths & Weaknesses
7.6 Boehringer Ingelheim
  7.6.1 Boehringer Ingelheim Details
  7.6.2 Boehringer Ingelheim Major Business
  7.6.3 Boehringer Ingelheim GLP-1 Drug Product and Services
  7.6.4 Boehringer Ingelheim GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Boehringer Ingelheim Recent Developments/Updates
  7.6.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.7 GlaxoSmithKline (GSK)
  7.7.1 GlaxoSmithKline (GSK) Details
  7.7.2 GlaxoSmithKline (GSK) Major Business
  7.7.3 GlaxoSmithKline (GSK) GLP-1 Drug Product and Services
  7.7.4 GlaxoSmithKline (GSK) GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 GlaxoSmithKline (GSK) Recent Developments/Updates
  7.7.6 GlaxoSmithKline (GSK) Competitive Strengths & Weaknesses
7.8 East China Pharmaceutical Co., Ltd.
  7.8.1 East China Pharmaceutical Co., Ltd. Details
  7.8.2 East China Pharmaceutical Co., Ltd. Major Business
  7.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Product and Services
  7.8.4 East China Pharmaceutical Co., Ltd. GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 East China Pharmaceutical Co., Ltd. Recent Developments/Updates
  7.8.6 East China Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.9 Gan & Lee Pharmaceuticals
  7.9.1 Gan & Lee Pharmaceuticals Details
  7.9.2 Gan & Lee Pharmaceuticals Major Business
  7.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Product and Services
  7.9.4 Gan & Lee Pharmaceuticals GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
  7.9.6 Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Tonghua Dongbao
  7.10.1 Tonghua Dongbao Details
  7.10.2 Tonghua Dongbao Major Business
  7.10.3 Tonghua Dongbao GLP-1 Drug Product and Services
  7.10.4 Tonghua Dongbao GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 Tonghua Dongbao Recent Developments/Updates
  7.10.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.11 Shanghai Renhui Biopharmaceutical Co., Ltd.
  7.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Details
  7.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. Major Business
  7.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product and Services
  7.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates
  7.11.6 Shanghai Renhui Biopharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
7.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
  7.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Details
  7.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
  7.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product and Services
  7.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
  7.12.6 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 GLP-1 Drug Industry Chain
8.2 GLP-1 Drug Upstream Analysis
  8.2.1 GLP-1 Drug Core Raw Materials
  8.2.2 Main Manufacturers of GLP-1 Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1 Drug Production Mode
8.6 GLP-1 Drug Procurement Model
8.7 GLP-1 Drug Industry Sales Model and Sales Channels
  8.7.1 GLP-1 Drug Sales Model
  8.7.2 GLP-1 Drug Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World GLP-1 Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World GLP-1 Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World GLP-1 Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World GLP-1 Drug Production Value Market Share by Region (2018-2023)
Table 5. World GLP-1 Drug Production Value Market Share by Region (2024-2029)
Table 6. World GLP-1 Drug Production by Region (2018-2023) & (K Units)
Table 7. World GLP-1 Drug Production by Region (2024-2029) & (K Units)
Table 8. World GLP-1 Drug Production Market Share by Region (2018-2023)
Table 9. World GLP-1 Drug Production Market Share by Region (2024-2029)
Table 10. World GLP-1 Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World GLP-1 Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. GLP-1 Drug Major Market Trends
Table 13. World GLP-1 Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World GLP-1 Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World GLP-1 Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World GLP-1 Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1 Drug Producers in 2022
Table 18. World GLP-1 Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key GLP-1 Drug Producers in 2022
Table 20. World GLP-1 Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global GLP-1 Drug Company Evaluation Quadrant
Table 22. World GLP-1 Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and GLP-1 Drug Production Site of Key Manufacturer
Table 24. GLP-1 Drug Market: Company Product Type Footprint
Table 25. GLP-1 Drug Market: Company Product Application Footprint
Table 26. GLP-1 Drug Competitive Factors
Table 27. GLP-1 Drug New Entrant and Capacity Expansion Plans
Table 28. GLP-1 Drug Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1 Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China GLP-1 Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China GLP-1 Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based GLP-1 Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1 Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers GLP-1 Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers GLP-1 Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers GLP-1 Drug Production Market Share (2018-2023)
Table 37. China Based GLP-1 Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1 Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers GLP-1 Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers GLP-1 Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers GLP-1 Drug Production Market Share (2018-2023)
Table 42. Rest of World Based GLP-1 Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers GLP-1 Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1 Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers GLP-1 Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers GLP-1 Drug Production Market Share (2018-2023)
Table 47. World GLP-1 Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World GLP-1 Drug Production by Type (2018-2023) & (K Units)
Table 49. World GLP-1 Drug Production by Type (2024-2029) & (K Units)
Table 50. World GLP-1 Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World GLP-1 Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World GLP-1 Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World GLP-1 Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World GLP-1 Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World GLP-1 Drug Production by Application (2018-2023) & (K Units)
Table 56. World GLP-1 Drug Production by Application (2024-2029) & (K Units)
Table 57. World GLP-1 Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World GLP-1 Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World GLP-1 Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World GLP-1 Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 62. Eli Lilly Major Business
Table 63. Eli Lilly GLP-1 Drug Product and Services
Table 64. Eli Lilly GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Eli Lilly Recent Developments/Updates
Table 66. Eli Lilly Competitive Strengths & Weaknesses
Table 67. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 68. AstraZeneca Major Business
Table 69. AstraZeneca GLP-1 Drug Product and Services
Table 70. AstraZeneca GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. AstraZeneca Recent Developments/Updates
Table 72. AstraZeneca Competitive Strengths & Weaknesses
Table 73. Sanofi Basic Information, Manufacturing Base and Competitors
Table 74. Sanofi Major Business
Table 75. Sanofi GLP-1 Drug Product and Services
Table 76. Sanofi GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Sanofi Recent Developments/Updates
Table 78. Sanofi Competitive Strengths & Weaknesses
Table 79. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Inc Major Business
Table 81. Pfizer Inc GLP-1 Drug Product and Services
Table 82. Pfizer Inc GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Pfizer Inc Recent Developments/Updates
Table 84. Pfizer Inc Competitive Strengths & Weaknesses
Table 85. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 86. Novo Nordisk Major Business
Table 87. Novo Nordisk GLP-1 Drug Product and Services
Table 88. Novo Nordisk GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novo Nordisk Recent Developments/Updates
Table 90. Novo Nordisk Competitive Strengths & Weaknesses
Table 91. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 92. Boehringer Ingelheim Major Business
Table 93. Boehringer Ingelheim GLP-1 Drug Product and Services
Table 94. Boehringer Ingelheim GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Boehringer Ingelheim Recent Developments/Updates
Table 96. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 97. GlaxoSmithKline (GSK) Basic Information, Manufacturing Base and Competitors
Table 98. GlaxoSmithKline (GSK) Major Business
Table 99. GlaxoSmithKline (GSK) GLP-1 Drug Product and Services
Table 100. GlaxoSmithKline (GSK) GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. GlaxoSmithKline (GSK) Recent Developments/Updates
Table 102. GlaxoSmithKline (GSK) Competitive Strengths & Weaknesses
Table 103. East China Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 104. East China Pharmaceutical Co., Ltd. Major Business
Table 105. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product and Services
Table 106. East China Pharmaceutical Co., Ltd. GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. East China Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 108. East China Pharmaceutical Co., Ltd. Competitive Strengths & Weaknesses
Table 109. Gan & Lee Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Gan & Lee Pharmaceuticals Major Business
Table 111. Gan & Lee Pharmaceuticals GLP-1 Drug Product and Services
Table 112. Gan & Lee Pharmaceuticals GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Gan & Lee Pharmaceuticals Recent Developments/Updates
Table 114. Gan & Lee Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 116. Tonghua Dongbao Major Business
Table 117. Tonghua Dongbao GLP-1 Drug Product and Services
Table 118. Tonghua Dongbao GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Tonghua Dongbao Recent Developments/Updates
Table 120. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 121. Shanghai Renhui Biopharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 122. Shanghai Renhui Biopharmaceutical Co., Ltd. Major Business
Table 123. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product and Services
Table 124. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Developments/Updates
Table 126. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 127. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Major Business
Table 128. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product and Services
Table 129. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of GLP-1 Drug Upstream (Raw Materials)
Table 131. GLP-1 Drug Typical Customers
Table 132. GLP-1 Drug Typical Distributors
List of Figure
Figure 1. GLP-1 Drug Picture
Figure 2. World GLP-1 Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World GLP-1 Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World GLP-1 Drug Production (2018-2029) & (K Units)
Figure 5. World GLP-1 Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World GLP-1 Drug Production Value Market Share by Region (2018-2029)
Figure 7. World GLP-1 Drug Production Market Share by Region (2018-2029)
Figure 8. North America GLP-1 Drug Production (2018-2029) & (K Units)
Figure 9. Europe GLP-1 Drug Production (2018-2029) & (K Units)
Figure 10. China GLP-1 Drug Production (2018-2029) & (K Units)
Figure 11. Japan GLP-1 Drug Production (2018-2029) & (K Units)
Figure 12. GLP-1 Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 15. World GLP-1 Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 17. China GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 22. India GLP-1 Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of GLP-1 Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for GLP-1 Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for GLP-1 Drug Markets in 2022
Figure 26. United States VS China: GLP-1 Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: GLP-1 Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: GLP-1 Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers GLP-1 Drug Production Market Share 2022
Figure 30. China Based Manufacturers GLP-1 Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers GLP-1 Drug Production Market Share 2022
Figure 32. World GLP-1 Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World GLP-1 Drug Production Value Market Share by Type in 2022
Figure 34. Short-acting GLP-1 Drug
Figure 35. Long-acting GLP-1 Drug
Figure 36. World GLP-1 Drug Production Market Share by Type (2018-2029)
Figure 37. World GLP-1 Drug Production Value Market Share by Type (2018-2029)
Figure 38. World GLP-1 Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World GLP-1 Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World GLP-1 Drug Production Value Market Share by Application in 2022
Figure 41. Obesity
Figure 42. Type 2 Diabetes (T2DM)
Figure 43. Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 44. Non-alcoholic Steatohepatitis (NASH)
Figure 45. Alzheimer's Disease (AD)
Figure 46. World GLP-1 Drug Production Market Share by Application (2018-2029)
Figure 47. World GLP-1 Drug Production Value Market Share by Application (2018-2029)
Figure 48. World GLP-1 Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. GLP-1 Drug Industry Chain
Figure 50. GLP-1 Drug Procurement Model
Figure 51. GLP-1 Drug Sales Model
Figure 52. GLP-1 Drug Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source